Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma and IntelGenx Announce the Signing of a Term Sheet for the Development and Commercialization of a Dronabinol XL Tablet

MarketWire Canada February 9, 2017

Tetra Bio-Pharma Inc. Enters into Distribution and Supply Agreement with Engen Medical Corporation

MarketWire Canada February 6, 2017

Tetra Bio-Pharma Inc. Receives Notice of Authorization from Health Canada for the Conduct of its Clinical Trial with its PPTGR topical product

MarketWire Canada February 1, 2017

Tetra Bio-Pharma Inc. Completes Pre-IND Meeting with Food and Drug Administration on PPP001

MarketWire Canada January 30, 2017

Tetra BioPharma Announces it Has Entered into a Clinical Research Partnership with Sante Cannabis, Quebec's Leading Medical Cannabis Institution

MarketWire Canada January 23, 2017

Popularity of Cannabis Products Increases in North America

PR Newswire January 18, 2017

Exclusive Interview with Tetra Bio-Pharma CSO Discussing Task Force Recommendations, DEA -- CFN Media

Marketwired January 17, 2017

Tetra Bio-Pharma Inc. Announces a New Appointment to its Scientific and Clinical Advisory Board

MarketWire Canada January 11, 2017

Tetra Bio-Pharma Inc. Enters Into Binding Letter of Intent for Co-Development and Commercialization of Health Care Products Containing Cannabinoids and Closes a Private Placement

MarketWire Canada January 10, 2017

Viridian Experts Talk Recent Cannabis Industry Deals: M&A, Capital Raises And IPOs

Benzinga.com  December 16, 2016

Tetra Bio-Pharma Looks to Make Cannabis Affordable -- CFN Media

Marketwired December 6, 2016

Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials

MarketWire Canada December 6, 2016

Tetra Bio-Pharma Provides USA Regulatory Update for its Cannabis Inhalation Product PPP001

MarketWire Canada November 23, 2016

Tetra Bio-Pharma Achieves DTC Eligibility in the United States

MarketWire Canada November 16, 2016

Tetra Bio-Pharma (GRPOF) Pioneers a New, Ancient Approach to Cannabinoid Delivery -- CFN Media

Marketwired November 14, 2016

Tetra Bio-Pharma Engages CFN Media to Build Market & Audience of Investors

Marketwired November 9, 2016

Tetra Bio-Pharma Inc. Announces the Closing of $914,456 Non-Brokered Private Placement

MarketWire Canada November 4, 2016

Tetra Bio-Pharma Announces Outcome of its Meeting with its Scientific and Clinical Advisory Board

MarketWire Canada November 2, 2016

Tetra Bio-Pharma Inc. Is Increasing Its $750,000 Non-Brokered Private Placement to $1,000,000

MarketWire Canada October 24, 2016

Tetra Bio-Pharma Inc. Announces a $750,000 Non-Brokered Private Placement & Granting of Options

MarketWire Canada October 20, 2016